Sharp Packaging Services provide unique and often complex commercial and clinical packaging solutions to the pharmaceutical industry with an international reputation for delivering cost-effective blister packaging, bottling, pouches and stick packs, compliance packaging, formulation and manufacturing services, label design and printing.

Sharp Clinical Services provides a range of services to support clinical trials, enabling clients to bring new medicines to the market quickly and securely. Services extend from clinical production, comparator sourcing, packaging and labelling through to storage and distribution (including cold chain). Trials are further supported through complementary services such as laboratory analysis, stability storage, European QP audit and release, and IRT capabilities. Sharp Clinical also provides analytical and research services delivered through Sharp’s laboratories, as well as clinical label design and randomisation services to ensure the integrity of the clinical trial, and preserve and enhance the value of our clients’ investment.

Sharp’s ‘pack-to-market’ solutions provide clinical and commercial packaging, storage, logistics and project management services, as well as a range of integrated complementary services, to pharmaceutical, biotech and clinical trial clients. Upcoming regulations on serialisation of prescription medicines in the US and Europe will have a major impact on the pharma and biotech industry. Sharp, a world leader in ‘Track and Trace’ packaging, is well positioned to capitalise on this change and strengthen its leadership position.

Sharp's  serialisation experience

Sharp Packaging Solutions provides unique and often complex commercial packaging solutions for both traditional blisters and bottles and specialty delivery systems. Solutions include blister packaging, bottling, pouches and sachets, stick packs, vial labelling, pre-filled syringe labelling and assembly and auto-injector pens. Sharp also provides sophisticated packaging and graphic design solutions enabling clients to create differentiation, adapt to changing regulations and implement late stage customisation to support product launches into new markets.

Sharp was an early adopter and innovator in serialisation technology that utilises ‘track and trace’ technology to protect patients and combat distribution of counterfeit medicines. Related regulations come into effect in the US in 2017 and in Europe from 2019, and Sharp currently has a significant number of new serialisation projects with new customers in its project pipeline.